Danaher Co. (NYSE:DHR) Shares Sold by Berger Financial Group Inc

by · The Cerbat Gem

Berger Financial Group Inc decreased its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 5.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 6,352 shares of the conglomerate’s stock after selling 366 shares during the quarter. Berger Financial Group Inc’s holdings in Danaher were worth $1,458,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Kentucky Retirement Systems Insurance Trust Fund boosted its position in shares of Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate’s stock worth $4,874,000 after buying an additional 2,202 shares during the period. ORG Partners LLC boosted its position in shares of Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after buying an additional 2,559 shares during the period. Generate Investment Management Ltd purchased a new position in shares of Danaher during the fourth quarter worth $8,044,000. Compass Capital Management Inc. boosted its position in shares of Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate’s stock worth $54,615,000 after buying an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC boosted its position in shares of Danaher by 42.8% during the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate’s stock worth $1,301,000 after buying an additional 1,698 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.4 %

DHR opened at $197.37 on Monday. The business’s 50-day simple moving average is $200.87 and its 200-day simple moving average is $223.98. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a one year low of $171.00 and a one year high of $281.70. The stock has a market capitalization of $141.06 billion, a P/E ratio of 37.38, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were given a dividend of $0.32 per share. The ex-dividend date was Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s payout ratio is 24.85%.

Insider Activity at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DHR. Citigroup reiterated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Guggenheim reiterated a “buy” rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Jefferies Financial Group decreased their target price on Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a report on Tuesday, April 22nd. Wells Fargo & Company decreased their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $264.40.

Read Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).